Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylsalicylic Acid as Add-on Treatment for Thrombotic Episodes in Superficial Venous Malformations in Children
NCT07663825Phase 2Not yet recruiting
- Sponsor
- University Hospital Tours
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in venous malformation (VM) comparing ASA + local NSAID then placebo + local NSAIDs with Placebo + local NSAID then AAS + local NSAIDs (2 arms). Primary endpoint: Total pain experienced during the episode up to 14 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on NCT07663825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07663825.